NYSE:NSPR InspireMD (NSPR) Stock Price, News & Analysis $0.77 +0.01 (+1.37%) Closing price 09/18/2026 04:00 PM EasternExtended Trading$0.77 +0.00 (+0.08%) As of 09/18/2026 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About InspireMD Stock (NYSE:NSPR) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get InspireMD alerts:Sign Up Key Stats Today's Range$0.76▼$0.8250-Day Range$0.65▼$0.9852-Week Range$0.63▼$2.57Volume19,862 shsAverage Volume143,852 shsMarket Capitalization$35.68 millionP/E RatioN/ADividend YieldN/APrice Target$4.50Consensus RatingBuy Company Overview InspireMD, Inc. (NYSE:NSPR) is a medical device company focused on developing and commercializing products for the treatment of vascular disease. The company’s primary focus is carotid artery disease, a condition in which plaque buildup can restrict blood flow and increase the risk of stroke. Its principal product is the CGuard Embolic Prevention System (EPS), a carotid stent system that combines a self-expanding stent with a fine mesh layer called MicroNet. The design is intended to stabilize plaque, reduce plaque protrusion through the stent, and help limit the release of embolic material during and after carotid artery procedures. InspireMD has also pursued regulatory clearances and commercial opportunities for its technology in international markets, including Europe and other regions, while seeking broader adoption in the United States. Founded in 2005 and based in Tel Aviv, Israel, InspireMD serves hospitals, physicians, and patients through a business focused on minimally invasive vascular interventions. Its products are designed for use by interventional cardiologists, vascular specialists, and other clinicians treating carotid and related vascular conditions.AI Generated. May Contain Errors. Read More Receive NSPR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InspireMD and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NSPR Stock News HeadlinesInspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 4, 2026 | globenewswire.comInspireMD, Inc. (NSPR) latest stock news and headlines – Yahoo FinanceSeptember 3, 2026 | uk.finance.yahoo.comThe hidden costs of a hands-off retirement accountContributing to your 401(k) consistently is good financial behavior - but contributing and optimizing are two different things. High fees, heavy company stock concentration, and target-date funds that follow a formula rather than your situation can quietly erode your balance over time. 74% of U.S. millionaires work with a financial advisor - more than double the general population rate. A fiduciary advisor can review your 401(k) for fees, allocation, and alignment with your actual timeline. SmartAsset's free quiz matches nearly 50,000 people each month with vetted fiduciary advisors in their area. | SmartAsset (Ad)InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment ConferenceSeptember 3, 2026 | globenewswire.comInspireMD, Inc. (NSPR) Q2 2026 Earnings Call TranscriptAugust 17, 2026 | seekingalpha.comInspireMD Reports Second Quarter 2026 Financial ResultsAugust 17, 2026 | globenewswire.comInspireMD Inc.August 12, 2026 | cnn.comInspireMD to Announce Second Quarter 2026 Financial ResultsAugust 10, 2026 | finance.yahoo.comSee More Headlines NSPR Stock Analysis - Frequently Asked Questions How have NSPR shares performed this year? InspireMD's stock was trading at $1.78 at the beginning of 2026. Since then, NSPR stock has decreased by 56.9% and is now trading at $0.7674. How were InspireMD's earnings last quarter? InspireMD, Inc. (NYSE:NSPR) issued its earnings results on Tuesday, November, 12th. The company reported ($0.16) earnings per share for the quarter, topping the consensus estimate of ($0.20) by $0.04. The company earned $1.81 million during the quarter, compared to the consensus estimate of $1.74 million. InspireMD had a negative trailing twelve-month return on equity of 69.42% and a negative net margin of 413.96%. When did InspireMD IPO? InspireMD (NSPR) raised $10,000 in an initial public offering (IPO) on Friday, May 21st 2021. The company issued 2,000,000 shares at a price of $0.00-$0.01 per share. Who are InspireMD's major shareholders? Top institutional shareholders of InspireMD include Nantahala Capital Management LLC (7.21%), Parkman Healthcare Partners LLC (5.16%), Velan Capital Investment Management LP (0.32%) and BlackRock Inc. (0.26%). Insiders that own company stock include Marvin Slosman, Shane Thomas Gleason, Gary S Roubin, Paul Stuka, Thomas J Kester and Scott R Ward. View institutional ownership trends. How do I buy shares of InspireMD? Shares of NSPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of InspireMD own? Based on aggregate information from My MarketBeat watchlists, some other companies that InspireMD investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), Disc Medicine (IRON), Jabil (JBL), Adobe (ADBE) and e.l.f. Beauty (ELF). Company Calendar Last Earnings11/12/2024Today9/19/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:NSPR CIK1433607 Webwww.inspiremd.com Phone9728887766804FaxN/AEmployees127Year FoundedN/APrice Target and Rating Average Price Target for InspireMD$4.50 High Price Target$6.00 Low Price Target$3.00 Potential Upside/Downside+486.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($0.64) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$19.92 million Net Margins-413.96% Pretax Margin-413.00% Return on Equity-69.42% Return on Assets-57.68% Debt Debt-to-Equity RatioN/A Current Ratio6.39 Quick Ratio6.05 Sales & Book Value Annual Sales$10.84 million Price / Sales3.29 Cash FlowN/A Price / Cash FlowN/A Book Value$1.83 per share Price / Book0.42Miscellaneous Outstanding Shares46,489,000Free Float18,332,000Market Cap$35.68 million OptionableOptionable Beta0.83 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NYSE:NSPR) was last updated on 9/20/2026 by MarketBeat.com Staff. From Our Partners“Elon’s nightmare” could fund your retirementMarc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...Chaikin Analytics | SponsoredYou’ve never seen anything like this beforeFor centuries, families like the Rothschilds, Morgans, and Rockefellers have quietly used one overlooked type ...Porter & Company | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredNVDA CEO says it’s a "once-in-a-generation opportunity"NVIDIA CEO Jensen Huang calls a little-known AI niche a once-in-a-generation opportunity, and it has nothing t...Monument Traders Alliance | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InspireMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InspireMD With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
